Friday, September 28
Breakfast
6:30 AM-7:45 AM

Friday, September 28
Lunch
11:45 AM-1:00 PM

Saturday, September 29
Breakfast
6:45 AM-8:00 AM

Saturday, September 29
Lunch
11:30 AM-12:45 PM

Sunday, September 30
Breakfast
7:00 AM-8:15 AM

Back to home

2007 Agenda: 2008 Agenda will be announced soon

The satellite symposia complement the information being presented during the regular meeting sessions. All are complimentary but registration is required as space is limited.

Refining Treatment Decisions for Patients with Early Stage Breast Cancer: Molecular – Based Assays

• Describe the limitations of clinically-based prognostic factors to determine risk of recurrence in patients with early stage breast cancer

• Describe the technology underlying the genomic assay or underlying the genomics-based assay currently available to assess risk of recurrence in patients with early stage
breast cancer

• Describe the results of the Oncotype DX validation studies for patients with axillary node negative, hormone receptor positive breast cancer patients

• Describe the rationale for the design of the TAILORx adjuvant trial•

Joseph Sparano, MD
Montefiore-Einstein Cancer Center

Terry Mamounas, MD
Aultman Cancer Center

Moderator
Virginia Kaklamani, MD, DSc
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Supported by an educational grant from Genomic Health.
This activity has been approved for 1.25 AMA PRA Category 1 Credit(s)™.

Back to Top